The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Universe Pharmaceuticals (NASDAQ: UPC) has officially announced the implementation of a dual-class share structure, set to take effect on February 13, 2026. Under the new arrangement, the company's authorized share capital of $20,000 will be restructured into two distinct classes of ordinary shares. This includes 1.8 billion Class A ordinary shares and 200 million Class B ordinary shares, aimed at refining the company's equity governance framework. Investors responded favorably to the news, driving the stock price up by 5.52% following the announcement. The strategic move is designed to optimize the company's capital structure and ensure long-term governance stability on the Nasdaq Capital Market. This restructuring highlights the company's commitment to evolving its financial architecture as it continues its operations in the pharmaceutical sector.
Sign in to access this content
Sign In